Crispr Therapeutics shares tumble after significant earnings miss
NVIDIA CORP (NASDAQ:NVDA), the semiconductor giant with a market capitalization of $3.77 trillion, saw its President and CEO Jen Hsun Huang sell a total of $30.4 million in company stock between June 24 and June 26, 2025. The sales, executed under a prearranged Rule 10b5-1 trading plan, involved multiple transactions with prices ranging from $146.1433 to $156.2868. According to InvestingPro data, these transactions occurred as NVIDIA’s stock traded near its 52-week high of $156.72.
On June 24, Huang sold 4,918 shares at a weighted average price of $146.1433, 42,013 shares at $147.1666 and 3,069 shares at $147.7522.
The following day, June 25, Huang continued selling shares, with 3,043 shares sold at an average price of $149.8507, 6,429 shares at $151.0466, 24,866 shares at $151.8086, 11,499 shares at $152.6631 and 28,277 shares at $153.7151 and 886 shares at $154.352.
The sales concluded on June 26, with 11,324 shares sold at an average price of $154.7779, 54,331 shares at $155.6449 and 9,345 shares at $156.2868.
Following these transactions, Huang directly owns 75,473,225 shares of NVIDIA CORP. He also indirectly owns a significant amount of shares through various trusts, partnerships and limited liability companies
In other recent news, Barclays (LON:BARC) has raised its price target for Nvidia to $200, maintaining an Overweight rating, citing a potential $2 billion upside for the company’s July quarter compared to consensus estimates. The firm increased its Compute revenue estimate to about $37 billion, up from $35.6 billion, and forecasts Nvidia’s quarterly revenue to reach $42 billion for the third calendar quarter. Meanwhile, Northrop Grumman (NYSE:NOC) is expanding its use of Nvidia technology to enhance AI applications for space operations, aiming to improve efficiency in spacecraft activities. Cyngn, another company leveraging Nvidia’s platform, was recently featured in a blog post by Nvidia, highlighting its use of the Isaac platform to develop autonomous industrial vehicles. SandboxAQ has released a large dataset using Nvidia chips to accelerate drug discovery, aiming to improve predictions of drug-protein binding. Additionally, Malaysia’s trade ministry is investigating reports of a Chinese firm using Nvidia AI chips in the country to train large language models, ensuring compliance with local regulations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.